Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 to 70 years old.~* Documented history of CIU for at least 6 weeks prior to entry in the study.~Exclusion Criteria:~* Dermatological pathology other than chronic idiopathic urticaria.~* History of autoimmune disorders, Hodgkin's disease, lymphoma, leukemia and generalized cancer.~* Pregnant or breast-feeding women.~* Patients who will be operating heavy machinery or need to drive motor vehicles as an essential part of their profession.~* Patients who have a recent history (within previous 12 months) of drug addiction or alcohol abuse.~* Patients who are currently participating in or have participated in another clinical trial within the last 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Bilastine 20 mg
- 2 (Type: ACTIVE_COMPARATOR): Levocetirizine 5 mg
- 3 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).